These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9708599)

  • 61. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A population study of the frequency of high-dose acetaminophen prescribing and dispensing.
    Albertson TE; Walker VM; Stebbins MR; Ashton EW; Owen KP; Sutter ME
    Ann Pharmacother; 2010; 44(7-8):1191-5. PubMed ID: 20551297
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Accuracy of pharmacy benefit manager medication formularies in an electronic health record system and the Epocrates mobile application.
    Andrus MR; Forrester JB; Germain KE; Eiland LS
    J Manag Care Spec Pharm; 2015 Apr; 21(4):281-6. PubMed ID: 25803761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
    Shih YC; Prasad M; Luce BR
    Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased Use of Complementary and Alternative Therapies for Back Pain Following Statewide Medicaid Coverage Changes in Oregon.
    Choo EK; Charlesworth CJ; Gu Y; Livingston CJ; McConnell KJ
    J Gen Intern Med; 2021 Mar; 36(3):676-682. PubMed ID: 33443692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Information needs for medication coverage decisions in a state Medicaid program.
    Croghan TW; Johnstone BM; Buesching DP; Kessler RC
    Med Care; 1999 Apr; 37(4 Suppl Lilly):AS24-31. PubMed ID: 10217390
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preferred drug lists: potential impact on healthcare economics.
    Ovsag K; Hydery S; Mousa SA
    Vasc Health Risk Manag; 2008; 4(2):403-13. PubMed ID: 18561515
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain.
    Wieder R; Delarosa N; Bryan M; Hill AM; Amadio WJ
    Pain Med; 2014 Jan; 15(1):42-51. PubMed ID: 24106748
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products.
    Tu CM
    Ther Innov Regul Sci; 2019 Jan; 53(1):132-137. PubMed ID: 29714596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Access to new medications to treat schizophrenia.
    Mark TL; Dirani R; Slade E; Russo PA
    J Behav Health Serv Res; 2002 Feb; 29(1):15-29. PubMed ID: 11840902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expecting patients to buy medicines OTC: is it fair?
    Shemtob L
    Br J Gen Pract; 2020 Apr; 70(693):180. PubMed ID: 32217583
    [No Abstract]   [Full Text] [Related]  

  • 72. How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians.
    Bachhuber MA
    Addict Sci Clin Pract; 2020 Jun; 15(1):20. PubMed ID: 32600402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost of medications for patients with ischemic heart disease in a rural family practice center.
    Patricoski CT; Steiner G
    J Am Board Fam Pract; 1999; 12(3):200-5. PubMed ID: 10395416
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic.
    Karlsson P; Nakitanda AO; Löfling L; Cesta CE
    PLoS One; 2021; 16(8):e0253944. PubMed ID: 34388166
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of medicaid access restrictions on statin utilisation for patients treated by physicians practising in poor and minority neighbourhoods.
    Headen AE; Masia NA; Axelsen KJ
    Pharmacoeconomics; 2006; 24 Suppl 3():41-53. PubMed ID: 17266387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost Implications of Escalating Intravenous Acetaminophen Use in Children.
    Bourgeois FT; Graham DA; Kesselheim AS; Randolph AG
    JAMA Pediatr; 2019 May; 173(5):489-491. PubMed ID: 30855654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes After a Statewide Policy to Improve Evidence-Based Treatment of Back Pain Among Medicaid Enrollees in Oregon.
    Choo EK; Charlesworth CJ; Livingston CJ; Hartung DM; El Ibrahimi S; Kraynov L; McConnell KJ
    J Gen Intern Med; 2024 Jun; ():. PubMed ID: 38951321
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Effect of Prescription Drug Coverage on Mortality: Evidence from Medicaid Implementation.
    Clayton DH
    J Health Econ; 2019 Jan; 63():100-113. PubMed ID: 30530251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The usage of over-the-counter products by private insured patients in Germany - a claims data analysis with focus on complementary medicine.
    Goetz K; Kalder M; Albert US; Jacke CO
    BMC Health Serv Res; 2020 Jul; 20(1):651. PubMed ID: 32660646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medication costs in different provider settings.
    Morehead MA; Lobach K; Lee J
    Qual Assur Util Rev; 1987 Aug; 2(3):71-8. PubMed ID: 2980908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.